What is the address of Dr.LAUWERS Mary - anesthesie?

The registered office of Dr.LAUWERS Mary - anesthesie is located at Tervuursesteenweg 102, 1981 Zemst.

Is Dr.LAUWERS Mary - anesthesie still active?

Yes. According to the CBE (29 September 2026) Dr.LAUWERS Mary - anesthesie is active, legal situation “Normale toestand”, started on 3 December 2010.

Is Dr.LAUWERS Mary - anesthesie registered on Peppol?

No, Dr.LAUWERS Mary - anesthesie is currently not registered on the Peppol network.

What is the enterprise number of Dr.LAUWERS Mary - anesthesie?

The enterprise number of Dr.LAUWERS Mary - anesthesie is BE0831598519.

When was Dr.LAUWERS Mary - anesthesie founded?

Dr.LAUWERS Mary - anesthesie was founded on 3 December 2010.

Who are the directors of Dr.LAUWERS Mary - anesthesie?

According to the 2024 annual accounts, the directors of Dr.LAUWERS Mary - anesthesie are: Mary Lauwers.

Is Dr.LAUWERS Mary - anesthesie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 December 2010; 4 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did Dr.LAUWERS Mary - anesthesie make in 2024?

Dr.LAUWERS Mary - anesthesie posted a profit after taxes of € 192,234 in financial year 2024.

What is the revenue of Dr.LAUWERS Mary - anesthesie?

As a small company, Dr.LAUWERS Mary - anesthesie is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 303,552.

Dr.LAUWERS Mary - anesthesie (Private Limited) - Zemst

Dossier Dr.LAUWERS Mary - anesthesie, printed on 29 September 2026 from databakkes.be/en/0831598519/dr-lauwers-mary-anesthesie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2024

Dr.LAUWERS Mary - anesthesie from Zemst, company number BE0831598519, closed financial year 2024 with a result of € 192,234 after tax. For that financial year Dr.LAUWERS Mary - anesthesie recorded a gross margin of € 303,552 and equity of € 753,408. Compared with financial year 2023, the result moved from € 141,526 to € 192,234. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 30, 2025.

What it is worth Growing

€ 753,408

▲ 16% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 192,234

▲ 36% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 291,916

▼ 23% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 85,601 paid out

45 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2024

Vehicles and equipment

€ 121,968

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 120,000

€ 24,000 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 7,605

▲ 10% vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 3,500

▼ 22% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2021	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 2,965 Gross margin 2021: € 2,965 First fiscal year in the series	€ 217,824 Gross margin 2022: € 217,824 ▲ € 214,859 vs 2021 (€ 2,965) Favourable step	€ 199,650 Gross margin 2023: € 199,650 ▼ 8% vs 2022 (€ 217,824) Unfavourable step	€ 303,552 Gross margin 2024: € 303,552 ▲ 52% vs 2023 (€ 199,650) Favourable step	▲ 52%
Profit after taxes	€ 793 Profit after taxes 2021: € 793 First fiscal year in the series	€ 152,318 Profit after taxes 2022: € 152,318 ▲ € 151,526 vs 2021 (€ 793) Favourable step	€ 141,526 Profit after taxes 2023: € 141,526 ▼ 7% vs 2022 (€ 152,318) Unfavourable step	€ 192,234 Profit after taxes 2024: € 192,234 ▲ 36% vs 2023 (€ 141,526) Favourable step	▲ 36%
Equity	€ 411,748 Equity 2021: € 411,748 First fiscal year in the series	€ 505,249 Equity 2022: € 505,249 ▲ 23% vs 2021 (€ 411,748) Favourable step	€ 646,775 Equity 2023: € 646,775 ▲ 28% vs 2022 (€ 505,249) Favourable step	€ 753,408 Equity 2024: € 753,408 ▲ 16% vs 2023 (€ 646,775) Favourable step	▲ 16%
Total debts	€ 17,096 Total debts 2021: € 17,096 First fiscal year in the series	€ 13,056 Total debts 2022: € 13,056 ▼ 24% vs 2021 (€ 17,096) Favourable step	€ 17,851 Total debts 2023: € 17,851 ▲ 37% vs 2022 (€ 13,056) Unfavourable step	€ 137,758 Total debts 2024: € 137,758 ▲ € 119,907 vs 2023 (€ 17,851) Unfavourable step	▲ € 119,907
Cash	€ 299,557 Cash 2021: € 299,557 First fiscal year in the series	€ 282,193 Cash 2022: € 282,193 ▼ 6% vs 2021 (€ 299,557) Unfavourable step	€ 376,884 Cash 2023: € 376,884 ▲ 34% vs 2022 (€ 282,193) Favourable step	€ 291,916 Cash 2024: € 291,916 ▼ 23% vs 2023 (€ 376,884) Unfavourable step	▼ 23%
Retained profit	€ 393,148 Retained profit 2021: € 393,148 First fiscal year in the series	€ 486,649 Retained profit 2022: € 486,649 ▲ 24% vs 2021 (€ 393,148) Favourable step	€ 628,175 Retained profit 2023: € 628,175 ▲ 29% vs 2022 (€ 486,649) Favourable step	€ 734,808 Retained profit 2024: € 734,808 ▲ 17% vs 2023 (€ 628,175) Favourable step	▲ 17%
Dividend	€ 65,827 Dividend 2021: € 65,827 First fiscal year in the series	€ 58,817 Dividend 2022: € 58,817 ▼ 11% vs 2021 (€ 65,827) Unchanged	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 58,817) Unchanged	€ 85,601 Dividend 2024: € 85,601 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2021: € 0 First fiscal year in the series	€ 0 Bank debt 2022: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 120,000 Bank debt 2024: € 120,000 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 428,844 Balance sheet total 2021: € 428,844 First fiscal year in the series	€ 518,305 Balance sheet total 2022: € 518,305 ▲ 21% vs 2021 (€ 428,844) Unchanged	€ 664,626 Balance sheet total 2023: € 664,626 ▲ 28% vs 2022 (€ 518,305) Unchanged	€ 891,166 Balance sheet total 2024: € 891,166 ▲ 34% vs 2023 (€ 664,626) Unchanged	▲ 34%

Key figures of Dr.LAUWERS Mary - anesthesie, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to Dr.LAUWERS Mary - anesthesie?

What happened at Dr.LAUWERS Mary - anesthesie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Oct 30, 2025 New annual accounts for financial year 2024: profit of € 192,234 (▲ 36% vs 2023). filed late Source: NBB ↗
2010 Mary Lauwers became a director. NBB
Dec 3, 2010 Start of the company according to the CBE. KBO
Nov 30, 2010 New establishment in Zemst. KBO

In short

From € 793 profit in 2021 to € 192,234 profit in 2024.

Paid € 211,902 in corporate taxes since 2021.

Best year ever: 2024, with € 192,234 profit.

Paid out € 210,245 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr.LAUWERS Mary - anesthesie? We notify you, reason included.

Follow Dr.LAUWERS Mary - anesthesie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Mary Lauwers

Dr.LAUWERS Mary - anesthesie

Behind Dr.LAUWERS Mary - anesthesie is Mary Lauwers.

See the full network in the app

Directors

According to the 2024 annual accounts

Mary Lauwers

Director

since 2010

Establishments

Establishment units

Physical locations of this company

Registered office

Tervuursesteenweg 102

1981 Zemst

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

DR CONVENS CARL

€ 764,872 gross margin · 2024

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0831.598.519
VAT number: BE 0831.598.519
Registered office: Tervuursesteenweg 102, 1981 Zemst
Names & denominations: Dr.LAUWERS Mary - anesthesie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 December 2010
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗